Company Profiles

driven by the PitchBook Platform

Andes Biotechnologies

Description

Developer and researcher of therapeutics to treat cancer. The company develops new anticancer therapies based on the inactivation of non-coding mitochondrial RNA targets through anti-sense and/or RNAi technology.

2008

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$4M

Total Amount Raised

2

Investors

Description

Developer and researcher of therapeutics to treat cancer. The company develops new anticancer therapies based on the inactivation of non-coding mitochondrial RNA targets through anti-sense and/or RNAi technology.

Website:

www.andesbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Drug Delivery

Primary Office

Parque Tecnológico Zañartu Av. Zañartu, Ñuñoa Santiago, 1482Chile +56 (0)2 367 2000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Andes Biotechnologies's full profile, request a free trial.

Andes Biotechnologies Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Andes Biotechnologies Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Aurus Gestion de InversionesVenture CapitalMinority000 0000000 0000
Austral Capital PartnersVenture CapitalMinority000 0000000 0000
Aurus Gestion de Inversiones Venture Capital
Austral Capital Partners Venture Capital

Andes Biotechnologies Executive Team (4)

NameTitleBoard
Seat
Contact
Info
Cristian Hernandez-CuevasChief Executive Officer
Pablo Valenzuela Ph.DPresident
Patricio CaceresChief Financial Officer
Luis BurzioChief Scientific Officer & Board Member
Cristian Hernandez-Cuevas Chief Executive Officer
Pablo Valenzuela Ph.D President
Patricio Caceres Chief Financial Officer
Luis Burzio Chief Scientific Officer & Board Member

Andes Biotechnologies Board Members (4)

NameRepresentingRoleSinceContact
Info
Alexander SeelenbergerAurus Gestion de InversionesGeneral Partner000 0000
Arturo Yudelevich Ph.DSelfBoard Member000 0000
Felipe CamposanoAustral Capital PartnersGeneral Partner000 0000
Luis BurzioAndes BiotechnologiesChief Scientific Officer & Board Member000 0000
Alexander Seelenberger General Partner Aurus Gestion de Inversiones
Arturo Yudelevich Ph.D Board Member Self
Felipe Camposano General Partner Austral Capital Partners
Luis Burzio Chief Scientific Officer & Board Member Andes Biotechnologies
Request full access to PitchBook